Quizartinib (AC220): a promising option for acute myeloid leukemia
Fang Zhou, Zheng Ge, Baoan ChenDepartment of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People’s Republic of ChinaAbstract: Quizartinib is an effective therapy for patients with FLT3-ITD a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-04-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/quizartinib-ac220-a-promising-option-for-acute-myeloid-leukemia-peer-reviewed-article-DDDT |